Hiroyuki Abe to Stomach Neoplasms
This is a "connection" page, showing publications Hiroyuki Abe has written about Stomach Neoplasms.
Connection Strength
2.185
-
Nationwide survey on HER2 and PD-L1 testing practices in gastric cancer across Japan. Gastric Cancer. 2025 Mar; 28(2):294-300.
Score: 0.705
-
Virus-host interactions in carcinogenesis of Epstein-Barr virus-associated gastric carcinoma: Potential roles of lost ARID1A expression in its early stage. PLoS One. 2021; 16(9):e0256440.
Score: 0.562
-
Stomach encyclopedia: Combined single-cell and spatial transcriptomics reveal cell diversity and homeostatic regulation of human stomach. Cell Rep. 2023 10 31; 42(10):113236.
Score: 0.163
-
Multiancestry genomic and transcriptomic analysis of gastric cancer. Nat Genet. 2023 04; 55(4):581-594.
Score: 0.156
-
Association of tumors having Epstein-Barr virus in surrounding lymphocytes with poor prognosis. Cancer Med. 2023 01; 12(2):1122-1136.
Score: 0.149
-
Selection of RNA-based evaluation methods for tumor microenvironment by comparing with histochemical and flow cytometric analyses in gastric cancer. Sci Rep. 2022 05 20; 12(1):8576.
Score: 0.148
-
Prediction of tissue origin of adenocarcinomas in the esophagogastric junction by DNA methylation. Gastric Cancer. 2022 03; 25(2):336-345.
Score: 0.141
-
Defined lifestyle and germline factors predispose Asian populations to gastric cancer. Sci Adv. 2020 05; 6(19):eaav9778.
Score: 0.128
-
Programmed cell death protein 1/programmed death ligand 1 but not HER2 is a potential therapeutic target in gastric neuroendocrine carcinoma. Histopathology. 2021 Feb; 78(3):381-391.
Score: 0.033